Bioprinting is a powerful technology in tissue and organ fabrication which has gained significant interest in medicine, biotech and pharmaceutics.
regenHU dedicates its engineering efforts on supporting the scientific community with cutting-edge bioprinting and biofabrication solutions to enable scientific advancements leading to the development of novel clinical products, therapies and solutions.
To date our bioprinting solutions are used for multidisciplinary applications, among other:
- Tissue engineering
- Regenerative & Personalized medicine
- Drug Screening & Development
- Fundamental Science to understand cell-cell/morphogens interactions and responses
- Functional Food
- Microfluidics, Lab & Organ-on-a-chip
- Academic Research & Education
- We will be delighted on supporting your activity with our expertise, passion & network.
In our ageing society, there is a huge medical need for therapies against degenerative muscle and tendon diseases. This study by researchers from ZHAW and Novartis Institutes for Biomedical Research describes a novel drug screening platform with automated production of 3D musculoskeletal-tendon-like tissues, representing a promising tool to address musculoskeletal diseases. Cells and bioink were printed using the 3DDiscovery™ bioprinter, in dumbbell lines designed by regenHU’s integrated BioCAD™ program.
Todays Dental News
Zeynep Aytac works with a 3D-Discovery Bioprinter at the University of Michigan School of Dentistry.
Adolphe Merkle Insitute, University of Fribourg
Working on a way to create a flexible bio-battery, researchers at the University of Fribourg used four compositions of hydrogel, and combined them to form a continuous series that mimicked the electric eel’s organized electrocytes anatomy. All hydrogel patterns were printed using a regenHU 3DDiscovery 3D bioprinter, with a custom print plate.
"My research is really awesome, because we're using 3D printers to create human body parts from scratch."
PhD candidate in Regenerative Medicine, Department of Orthopaedics, UMC Utrecht
ETH Zürich "ETH researchers have developed a biocompatible ink for 3D printing using living bacteria. This makes it possible to produce biological materials capable of breaking down toxic substances or producing high-purity cellulose for biomedical applications." Complete press-release : ETH Zürich website Press link : Compamed Magazine
University Medical Center Utrecht and the Istituto Ortopedico Rizzoli
Engineering Complex Bioarchitectures To Biomimic Nature : A Step Closer To The Development Of Artificial Tissue & Organs
This achievement is the result of significant contribution from the University Medical Center Utrecht and the Istituto Ortopedico Rizzoli